Archive for the ‘MitoPharm Corp. MTPH’ Category

Beacon Equity Research Featured Company: MitoPharm Corp. (MTPH.OB)

Thursday, January 31st, 2008

MitoPharm Corporation (MTPH.OB) is a biotechnology company that is still in its development stage. The Company researches, develops and markets functional beverages, dietary supplements and drugs. To research and develop new drugs, the company uses up to date technology in biochemistry, pharmacology, and Traditional Chinese Medicinal formulas.

Mitopharm has two primary products: Restorade and Stamina Solution. Both products are based on a new compound that has biochemical properties to aid in countering the aging process. By increasing the body’s stamina and the mitochondrial function of important organs, the products aid in overall health, vitality and energy levels. Restorade and Stamina Solution are both made from natural ingredients and have been shown to have no adverse side effects.

Biotechnology is showing to be a fast growing sector of the healthcare market. Globally, revenues in this market increased from $22.3 billion in 2000 to approximately $50 billion in 2005. As the population in the United States continues to age, spending on health care is expected to maintain a steady ascent.

Let us hear your thoughts: MitoPharm Corp. Message Board